The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism - or inverse agonism - as potential obesity treatment and other therapeutic use
Xie, S., Furjanic, M. A., Ferrara, J. J., McAndrew, N. R., Ardino, E. L., Ngondara, A., Bernstein, Y., Thomas, K. J., Kim, E., Walker, J. M., Nagar, S., Ward, S. J., Raffa, R. B.
Published in Journal of clinical pharmacy and therapeutics (01.06.2007)
Published in Journal of clinical pharmacy and therapeutics (01.06.2007)
Get full text
Journal Article
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB 1 receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use
Xie, S., Furjanic, M. A., Ferrara, J. J., McAndrew, N. R., Ardino, E. L., Ngondara, A., Bernstein, Y., Thomas, K. J., Kim, E., Walker, J. M., Nagar, S., Ward, S. J., Raffa, R. B.
Published in Journal of clinical pharmacy and therapeutics (01.06.2007)
Published in Journal of clinical pharmacy and therapeutics (01.06.2007)
Get full text
Journal Article
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB sub(1) receptor antagonism - or inverse agonism - as potential obesity treatment and other therapeutic use
Xie, S, Furjanic, MA, Ferrara, J J, McAndrew, N R, Ardino, EL, Ngondara, A, Bernstein, Y, Thomas, K J, Kim, E, Walker, J M, Nagar, S, Ward, S J, Raffa, R B
Published in Journal of clinical pharmacy and therapeutics (01.06.2007)
Published in Journal of clinical pharmacy and therapeutics (01.06.2007)
Get full text
Journal Article